BD Board Declares Dividend

                          BD Board Declares Dividend

PR Newswire

FRANKLIN LAKES, N.J., Jan. 29, 2013

FRANKLIN LAKES, N.J., Jan. 29, 2013 /PRNewswire/ -- The Board of Directors of
BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly
dividend of 49.5 cents per common share, payable on March 29, 2013 to holders
of record on March 8, 2013. The indicated annual dividend rate is $1.98 per

About BD
BD is a leading global medical technology company that develops, manufactures
and sells medical devices, instrument systems and reagents. The Company is
dedicated to improving people's health throughout the world. BD is focused on
improving drug delivery, enhancing the quality and speed of diagnosing
infectious diseases and cancers, and advancing research, discovery and
production of new drugs and vaccines. BD's capabilities are instrumental in
combating many of the world's most pressing diseases. Founded in 1897 and
headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000
associates in more than 50 countries throughout the world. The Company serves
healthcare institutions, life science researchers, clinical laboratories, the
pharmaceutical industry and the general public. For more information, please

Colleen T. White, Corporate Communications – 201-847-5369
Monique N. Dolecki, Investor Relations – 201-847-5378

SOURCE BD (Becton, Dickinson and Company)

Press spacebar to pause and continue. Press esc to stop.